Search results for "Random"

showing 10 items of 3931 documents

Influence of marginal bone loss on peri-implantitis : systematic review of literature

2019

Background The marginal bone of dental implants is subjected to slight load modifications over time, conditioning implant survival. Objective: Perform a systematic review of the literature analyzing the factors that contribute to marginal bone loss (MBL) and the subsequent development of peri-implantitis. Material and methods Bibliographic research in the databases PubMed, Medline and Scopus between 2010 and 2018 was performed. The inclusion criteria were articles published in the last 10 years and that were in English or Spanish, that were carried out on humans, that were cohort studies, that included cases and controls or that used randomized clinical trials. Exclusion criteria removed ar…

Peri-implantitisbusiness.industrymedicine.medical_treatmentMEDLINEDentistry030206 dentistryReview:CIENCIAS MÉDICAS [UNESCO]law.invention03 medical and health sciences0302 clinical medicineSystematic reviewRandomized controlled triallawUNESCO::CIENCIAS MÉDICASmedicine030212 general & internal medicineImplantOral SurgerybusinessDental implantProspective cohort studyGeneral DentistryCohort study
researchProduct

Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta‐…

2017

Objective To assess the efficacy of vaginal progesterone for the prevention of preterm birth and neonatal morbidity and mortality in asymptomatic women with a twin gestation and a sonographic short cervix (cervical length ≤ 25 mm) in the mid-trimester. Methods This was an updated systematic review and meta-analysis of individual patient data (IPD) from randomized controlled trials comparing vaginal progesterone with placebo/no treatment in women with a twin gestation and a mid-trimester sonographic cervical length ≤ 25 mm. MEDLINE, EMBASE, POPLINE, CINAHL and LILACS (all from inception to 31 December 2016), the Cochrane Central Register of Controlled Trials, Research Registers of ongoing tr…

Perinatal DeathCervix Uterilaw.inventiontransvaginal ultrasound0302 clinical medicineRandomized controlled trialObstetrics and gynaecologyPregnancylawInfant Mortality030212 general & internal medicineProgesteroneRandomized Controlled Trials as Topic030219 obstetrics & reproductive medicineRadiological and Ultrasound TechnologyObstetricsObstetrics and GynecologyGeneral MedicineMaternal MortalityTreatment OutcomePremature BirthGestationFemalemedicine.symptompreterm deliverymedicine.medical_specialtySystematic ReviewsBirth weightPlaceboAsymptomatic03 medical and health sciencesmedicineHumansRadiology Nuclear Medicine and imagingGynecologyFetusbusiness.industryprematurityInfant NewbornInfantprogestogenscervical lengthAdministration IntravaginalReproductive MedicineprogestinsRelative riskMaternal DeathPregnancy TwinSystematic ReviewbusinessUltrasound in Obstetrics & Gynecology
researchProduct

Comparative assessment of plaque removal and motivation between a manual toothbrush and an interactive power toothbrush in adolescents with fixed ort…

2019

Introduction The objective of this 2-arm parallel trial was to determine the plaque removal efficacy (main outcome) and the motivation assessment (secondary outcome) comparing a manual versus an interactive power toothbrush in orthodontic patients. Methods Sixty adolescents with fixed orthodontic appliances in both arches were randomized in a 1:1 ratio in this parallel, randomized, examiner-blind controlled clinical trial. Eligibility criteria included at least 16 natural teeth, 1-6 “focus care areas,” plaque score of ≥1.75, no severe caries, gingivitis and periodontitis, no dental prophylaxis, no smoking, no antibiotics, and no chlorhexidine mouth rinse. Subjects were to brush unsupervised…

Periodontitisbusiness.industryDental ProphylaxisChlorhexidineDentistryOrthodontics030206 dentistrymedicine.diseaseSingle CenterDental Plaque Indexlaw.inventionClinical trial03 medical and health sciencesGingivitis0302 clinical medicineRandomized controlled triallawMedicinemedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugAmerican Journal of Orthodontics and Dentofacial Orthopedics
researchProduct

Effects of timing of adjunctive systemic antibiotics on the clinical outcome of periodontal therapy : a systematic review

2019

Background Many systematic reviews and meta-analysis have indicated beneficial effects of adjunctive systemic antibiotics in periodontal therapy in specific situations. However, some essential issues such as the ideal time of their administration during periodontal therapy remain unanswered. This systematic review aimed to determine at which phase of periodontal treatment would adjunctive systemic antibiotics lead to the best clinical outcomes, during the active phase or in the reevaluation phase. Material and methods Searches in the databases Medline, Scopus and Cochrane Library were conducted. The randomized clinical trials and retrospective cohort studies comparing the clinical benefits …

Periodontitismedicine.medical_specialtyGingival and periodontal pocketbusiness.industryMEDLINERetrospective cohort studyReview030206 dentistryCochrane Librarymedicine.disease:CIENCIAS MÉDICAS [UNESCO]law.invention03 medical and health sciences0302 clinical medicineSystematic reviewRandomized controlled trialClinical attachment losslawUNESCO::CIENCIAS MÉDICASmedicinePeriodontology030212 general & internal medicineIntensive care medicinebusinessGeneral Dentistry
researchProduct

Healing of intrabony defects following surgical treatment with or without an Er:YAG laser. A pilot study

2004

Aim: The aim of this controlled, parallel design clinical study was to compare the healing of intrabony periodontal defects following treatment with access flap surgery with and without debridement with an Er:YAG laser. Methods: Twenty-three patients each of whom exhibited one deep intrabony defect were randomly treated with either access flap surgery followed by root surface and defect debridement using an Er:YAG laser (KEY3®) (160 mJ, 10 Hz) (test), or with access flap surgery followed by root surface and defect debridement using hand and ultrasonic instruments (control). The following clinical parameters were recorded at baseline and at 6 months: plaque index; gingival index; bleeding on…

Periodontitismedicine.medical_specialtybusiness.industrymedicine.medical_treatmentBleeding on probingDentistrymedicine.diseaselaw.inventionSurgeryRandomized controlled triallawDebridement (dental)medicinePeriodonticsmedicine.symptombusinessProspective cohort studyAdverse effectGingival recessionEr:YAG laserJournal of Clinical Periodontology
researchProduct

The physical mechanisms of relaxation times distribution in inorganic and organic disordered ferroelectrics

2007

Abstract We discuss the physical background for relaxation times distribution in organic and inorganic disordered ferroelectrics. We show that such background is a disorder which is believed to be a reason for relaxor behavior. Due to this disorder the internal electric and elastic fields are of a random nature being characterized by certain distribution function. Having the distribution function f ( E ) of random field E , we can obtain the distribution function of relaxation times F ( τ ) with the help of relation between τ and E . Latter relation can be obtained considering the dynamics of a single electric dipole in a random field created by the ensemble of defects and impurities in a s…

PermittivityRandom fieldCondensed matter physicsDistribution (number theory)ChemistryRelaxation (NMR)DielectricCondensed Matter PhysicsFerroelectricityElectronic Optical and Magnetic MaterialsDipoleDistribution functionMaterials ChemistryCeramics and CompositesJournal of Non-Crystalline Solids
researchProduct

Aceclofenac cream versus piroxicam cream in the treatment of patients with minor traumas and phlogistic affections of soft tissues: a double-blind st…

1995

Abstract The efficacy and safety of aceclofenac 1.5% cream and piroxicam 1% cream in 220 patients with soft-tissue injuries were evaluated in a double-blind, randomized, multicenter, comparative, parallel-group trial. Patients were randomly assigned to each treatment group to receive therapy three times a day for 7 days. The primary outcome measure of pain was evaluated using a visual analog scale (VAS) at baseline, day 4, and day 7 of the study. Safety was assessed by recording any adverse events that occurred and by monitoring any hemato-biochemical alterations during the study. After days 4 and 7 of treatment, a significant improvement ( P P

PharmacologyChemotherapymedicine.medical_specialtyRandomizationbusiness.industryVisual analogue scalemedicine.medical_treatmentSoft tissuePiroxicamSurgeryDouble blind studyAnesthesiaMedicineAceclofenacPharmacology (medical)businessAdverse effectmedicine.drugCurrent Therapeutic Research
researchProduct

Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patients.

2012

Breakthrough cancer pain has been defined as a transitory increase in pain intensity that occurs either spontaneously or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain. The availability of supplemental doses of oral opioids, in addition to the continuous analgesic medication, is the main treatment suggested to manage pain flares.Oral transmucosal fentanyl citrate (OTFC) is the first product of a new generation of delivery systems, named rapid-onset opioids (ROOs), characterized by rapidity of effect and the short duration of analgesia. Controlled studies and long-term experience have shown that OTFC is an e…

PharmacologyClinical Trials as Topicbusiness.industryBreakthrough PainAnalgesicBreakthrough PainMouth MucosaCancerAdministration OralGeneral Medicinemedicine.diseaseFentaNYL CitratePain ladderAnalgesics OpioidFentanylAnesthesiaNeoplasmsmedicineEffective treatmentHumansPharmacology (medical)Onset of actionCancer painbusinessRandomized Controlled Trials as TopicExpert opinion on pharmacotherapy
researchProduct

Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of mar…

2012

Hermann et al. [1] suggest that minimum quality criteria are needed to communicate unexpected drug safety findings from randomized clinical trials and imply that our report on unexpected frequent hepatotoxicity in patients receiving flupirtine for the treatment of overactive bladder syndrome [2] does not meet such criteria. As the brief report format of our paper did not allow an extensive description of trial details, we welcome this opportunity to shed more light on the matter.

PharmacologyDrugmedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectOveractive bladder syndromelaw.inventionSurgeryRandomized controlled triallawMarketed productsmedicinePharmacology (medical)Quality (business)In patientIntensive care medicinebusinessmedia_commonBritish Journal of Clinical Pharmacology
researchProduct

Thrombolysis plus heparin versus heparin alone in the acute phases of unstable angina: preliminary findings

1995

Abstract Several studies have shown conflicting effects of thrombolysis in patients with unstable angina. In these trials the time between presentation with chest pain and randomization was long (12 hours to 3 days). This study compared thrombolysis and heparin with heparin-alone treatment in patients in the acute phase of unstable angina. One hundred fifty-three consecutive patients hospitalized with chest pain at rest (first episode) lasting >5 minutes but P = 0.013). Data suggest that thrombolysis plus heparin produces faster clinical stabilization than heparin alone in patients treated during the acute phase of unstable angina.

PharmacologyFirst episodemedicine.medical_specialtyRandomizationT-plasminogen activatorbusiness.industrymedicine.drug_classUnstable anginamedicine.medical_treatmentAnticoagulantHeparinThrombolysisChest painmedicine.diseaseSurgeryAnesthesiamedicinePharmacology (medical)medicine.symptombusinessmedicine.drugCurrent Therapeutic Research
researchProduct